Elisa Fabbrini

9.4k citations
60 papers · 7.3k indexed · 3 hit papers · h-index 33

Impact in

Papers in

Elisa Fabbrini

59 papers receiving 7.2k citations

Hit Papers

Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events 2017 · 375 citations
375200920262014202050010001.5k

Peers

Elisa Fabbrini
Comparison fields: 5 of 128
  • Endocrinology, Diabetes and Metabolism 2.9k
  • Epidemiology 3.8k
  • Physiology 2.6k
  • Biochemistry 490
  • Endocrine and Autonomic Systems 393
Replace Michael J. Jurczak with:
Michael J. Jurczak United States
Leanne Hodson United Kingdom
João Paulo Camporez United States
Tsuguhito Ota Japan
R. Scott Rector United States
B. Selma Mohammed United States
Michael J. Pagliassotti United States
Bettina Mittendorfer United States
François R. Jornayvaz Switzerland
Nicola Santoro United States
Elisa Fabbrini relative to Michael J. Jurczak United States Michael J. Jurczak's profile →
Citations per field
00.5×1.5×
Michael J. Jurczak · 1×
Citations per year

Countries citing papers authored by Elisa Fabbrini

Since Specialization
Citations

This map shows the geographic impact of Elisa Fabbrini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Fabbrini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Fabbrini more than expected).

Fields of papers citing papers by Elisa Fabbrini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Fabbrini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Fabbrini. The network helps show where Elisa Fabbrini may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Elisa Fabbrini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Elisa Fabbrini Line = papers co-authored together Elisa Fabbrini links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 201990
3 20185
4
Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events
Hit paper breakdown →
2017375
5 201538
6 2013227
7 201231
8 201276
9 2012155
10 2010143
11 201033
12
Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity
Hit paper breakdown →
2009762
13 20092
14 200911
15 2008392
16 200829
17 200872
18 2007451
19 200071
20 2000163

About Elisa Fabbrini

Elisa Fabbrini is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology, Epidemiology, Endocrine and Autonomic Systems and Family Practice, having authored 60 papers that have together received 7.3k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (20 papers), Diet and metabolism studies (12 papers), Adipose Tissue and Metabolism (11 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers), Diet, Metabolism, and Disease (9 papers), Diabetes Treatment and Management (9 papers), Adipokines, Inflammation, and Metabolic Diseases (7 papers) and Bariatric Surgery and Outcomes (7 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.9k citations), Epidemiology (3.8k citations), Physiology (2.6k citations), Biochemistry (490 citations) and Endocrine and Autonomic Systems (393 citations). Elisa Fabbrini has collaborated with scholars based in United States, Italy and Greece. Frequent co-authors include Samuel Klein, Shelby Sullivan, Faidon Magkos, B. Selma Mohammed, Bruce W. Patterson, Kevin Korenblat, Adewole L. Okunade, J. Christopher Eagon, Terri Pietka and Nada A. Abumrad. Their work appears in journals such as Obesity, Gastroenterology, The Journal of Clinical Endocrinology & Metabolism, Diabetes and Journal of Lipid Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026